Pharming Group N.V. (PHAR) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.02
-0.01
-0
0.01

Details

Expected EPS
0.0001
Actual EPS
-0.007
Surprise EPS
-0.01
Surprise Percent
+7,100%

Description

Pharming Group N.V. (PHAR) has reported earnings of -0.007 per share for Q2 2026.

0 Comments

Share your thoughts